Генетика дофаминэргической системы: сравнение аддикций и болезни Паркинсона
https://doi.org/10.31363/2313-7053-2019-4-1-36-38
Аннотация
Об авторах
З. Карл ЛинСоединённые Штаты Америки
Ф. С. Холл
Соединённые Штаты Америки
Р. Л. Бэлл
Соединённые Штаты Америки
Список литературы
1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223-33. Epub 2009/06/30. doi: 10.1016/s0140-6736(09)60746-7. PubMed PMID: 19560604.
2. Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384(9937):45-52. Epub 2014/07/06. doi: 10.1016/s0140-6736(14)60648-6. PubMed PMID: 24996589.
3. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287-323. Epub 2015/09/15.
4. doi: 10.1016/s0140-6736(15)00128-2. PubMed PMID: 26364544; PubMed Central PMCID: PMCPmc4685753.
5. Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393(10190):2493-502. Epub 2019/05/12. doi: 10.1016/s0140-6736(18)32744-2. PubMed PMID: 31076174.
6. Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2015. Epub 2015/10/12. doi: 10.1016/s0140-6736(15)00390-6. PubMed PMID: 26454360.
7. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-858. Epub 2018/11/30. doi: 10.1016/s0140-6736(18)32279-7. PubMed PMID: 30496104; PubMed Central PMCID: PMCPMC6227754.
8. Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241-50. Epub 2017/11/16. doi: 10.1016/s0140-6736(17)31869-x. PubMed PMID: 29137869; PubMed Central PMCID: PMCPMC5803132.
9. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-88. Epub 2018/11/30. doi: 10.1016/s0140-6736(18)32203-7. PubMed PMID: 30496103; PubMed Central PMCID: PMCPMC6227606.
10. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019. Epub 2019/06/30. doi: 10.1016/s01406736(19)30427-1. PubMed PMID: 31248666.
11. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nature reviews Genetics. 2005;6(7):521-32. Epub 2005/07/05. doi: 10.1038/nrg1635. PubMed PMID: 15995696.
12. Zhao Y, Yu J, Zhao J, Chen X, Xiong N, Wang T, et al. Intragenic Transcriptional cis-Antagonism Across SLC6A3. Molecular neurobiology. 2018. Epub 2018/09/28. doi: 10.1007/s12035-018-13575. PubMed PMID: 30259411.
13. Liu K, Yu J, Zhao J, Zhou Y, Xiong N, Xu J, et al. (AZI2)3’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders. Molecular neurobiology. 2018;55(7):5611-22. Epub 2017/10/07. doi: 10.1007/ s12035-017-0781-2. PubMed PMID: 28983843; PubMed Central PMCID: PMCPMC5886844.
14. Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nature protocols. 2010;5(9):1564-73. Epub 2010/11/19. doi: 10.1038/nprot.2010.116. PubMed PMID: 21085122; PubMed Central PMCID: PMCPmc3025522.
15. Bahi A, Dreyer JL. No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice. Psychopharmacology. 2018. Epub 2018/12/13. doi: 10.1007/ s00213-018-5144-9. PubMed PMID: 30539268.
Рецензия
Для цитирования:
Карл Лин З., Холл Ф.С., Бэлл Р.Л. Генетика дофаминэргической системы: сравнение аддикций и болезни Паркинсона. Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева. 2019;(4-1):36-38. https://doi.org/10.31363/2313-7053-2019-4-1-36-38
For citation:
Carl Lin Z., Hall F.S., Bell R.L. Dopamine Genetics: Substance Use Disorders vs. Parkinson’s Disease. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(4-1):36-38. https://doi.org/10.31363/2313-7053-2019-4-1-36-38